XML 52 R3.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Operations - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Revenues      
Total revenues € 482,325 € 108,589 € 127,575
Cost of sales (59,333) (17,361) (13,690)
Research and development expenses (645,029) (226,466) (143,040)
Sales and marketing expenses (14,512) (2,718) (3,041)
General and administrative expenses (94,049) (45,547) (26,334)
Other operating expenses (2,358) (739) (720)
Other operating income 250,539 2,724 5,396
Operating loss (82,417) (181,518) (53,854)
Finance income [1] 1,564 4,122 8,046
Finance expenses [1] (62,946) (326) (48)
Interest expenses related to lease liabilities (2,003) (1,718) (1,721)
Share of loss of equity method investees     (84)
Loss before tax (145,802) (179,440) (47,662)
Income taxes 161,000 268 (600)
Profit / (Loss) for the period 15,198 (179,172) (48,262)
Attributable to:      
Equity holders of the parent 15,198 (179,056) (48,019)
Non-controlling interests   (116) (243)
Profit / (Loss) for the period € 15,198 € (179,172) € (48,262)
Earnings per share      
Basic and diluted, profit / (loss) for the period attributable to ordinary equity holders of the parent [2] € 0.06 € (0.85) € (0.25)
Research & Development      
Revenues      
Total revenues € 178,849 € 84,428 € 101,837
Commercial      
Revenues      
Total revenues 303,476 24,161 25,738
Cost of sales € (59,333) € (17,361) € (13,690)
[1] Foreign exchange differences on a cumulative basis are shown either as finance income or expenses and might switch between those two positions during the year-to-date reporting periods.
[2] Numbers of shares for calculating the earnings per share for the years ended December 31, 2019 and December 31, 2018 have been adjusted to reflect capital increase due to 1:18 share split, which occurred on September 18, 2019.